Arca
Skip to content

Zilurgisertib Fumarate

Sold as Atebrioz. Every branded application for this active ingredient.

  • First approved: Sep 25, 2026
  • Branded applications: 1
  • New uses approved: 0
  • Complete response letters: 0

Applications

NDAs and BLAs for this ingredient, oldest first; each opens its full history
ApprovedApplicationSponsorSupplementsMarketing
Sep 25, 2026AtebriozNDA 221198 · New molecular entityMirum0Marketed

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Drugs@FDA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.